Complementing the Legal Network’s earlier detailed legal analysis of Bill S-232’s proposed reforms to Canada’s Access to Medicines Regime (CAMR), this supplementary submission outlines in summary form the key issues and the provisions of WTO law that permit Canada to simplify the current CAMR as proposed by Bill S-232, while complying with its legal obligations as a WTO Member, and in some instances, making CAMR even more consistent with TRIPS by taking advantage of explicit flexibilities not currently in CAMR.

Download